Thousands of patients prescribed high-risk drugs
Thousands of patients in Scotland who are particularly vulnerable to adverse drug events (ADEs) were prescribed high-risk medications by their GPs which could potentially cause them harm, according to research published in the British Medical Journal today.
Although at least some of this prescribing will be appropriate because prescribers and patients are balancing risks and benefits when there may be no clearly 'correct' course of action, the study also finds that there was significant variation in the prescribing practices between the GPs surgeries surveyed. This variation could not be explained by the patient case mix which suggests that there is considerable scope to improve prescribing practices, say the researchers.
The authors, led by Professor Bruce Guthrie from Dundee University, say that previous studies have shown that GP prescribing can cause considerable harm, and they highlight that "adverse drug events (ADEs) account for 6.5% of all hospital admissions, over half of which are judged to be preventable".
Patients could be vulnerable to high risk drugs because of their age, other existing illnesses or because of other prescription medications they may be on. GPs need to be alert to these risk factors and be cautious about the drugs they prescribe to these patients, say the authors.
A number of medications or scenarios are already flagged up as high risk, for example, non-steroidal anti-inflammatory drugs for certain patients, prescribing a new drug when a patient is on the blood-thinning medication warfarin, prescribing drugs when patients have heart failure and prescribing antipsychotic drugs for patients who have dementia.
Guthrie and colleagues expanded the list above and developed 15 indicators to examine how often patients vulnerable to ADEs were prescribed high-risk medication that could harm them.
The authors used the indicators to review data from 315 Scottish General Practices with 1.76 million patients, of which 139,404 (7.9%) were identified as being particularly vulnerable to ADEs.
The results show that 19,308 (13.9%) who were in the vulnerable group were prescribed one or more high-risk medications.
While the authors emphasise that not all high-risk prescribing is inappropriate they conclude that the study shows "that opportunities to improve primary care prescribing safety are considerable" across the UK.
Provided by
British Medical Journal
-
Article outlines principles for a conservative approach to prescribing medication
Jun 13, 2011 |
not rated yet |
0
-
One-in-six elderly dementia patients receiving anti-psychotic drugs
Jul 23, 2010 |
not rated yet |
0
-
Electronic prescribing system may encourage physicians to choose lower-cost drugs
Dec 08, 2008 |
not rated yet |
0
-
Study examines prescribing of antipsychotic medications for nursing home residents
Jan 11, 2010 |
not rated yet |
0
-
Physicians click their way to better prescriptions
Mar 10, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Breakup of physician, drug company relationship could improve health care, cut cost
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
Medications
10 hours ago |
5 / 5 (1) |
0
FDA has safety concerns on Merck insomnia drug
Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.
Medications
11 hours ago |
not rated yet |
0
US adviser on board of firm that sold anthrax drug
(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...
Medications
18 hours ago |
5 / 5 (1) |
0
Acne pill benefits outweigh blood clot risk: EU agency
Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.
Medications
May 17, 2013 |
not rated yet |
0
First influenza vaccine brought to clinical testing
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...
Medications
May 17, 2013 |
5 / 5 (1) |
1
The compound in the Mediterranean diet that makes cancer cells 'mortal'
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
Do salamanders hold the solution to regeneration?
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
Scientists identify molecular trigger for Alzheimer's disease
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
Practice makes perfect? Not so much
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
Older prostate cancer patients should think twice before undergoing treatment
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
New test better detects elephantiasis worm infection
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...